Clinical Trial Update: Drug Drug Interaction Study Between BI 201335 and BI 207127 in Chronic Hepatitis C Infected Patients [Phase 1]

View source ↗

Summary

Phase 1 study assessing drug-drug interaction between BI 201335 and BI 207127 in adults with chronic hepatitis C; results have been posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• BI 201335
• BI 207127 (BI-207127)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Hepatitis C, Chronic | Phase 1 | Status: COMPLETED | Results posted: 2016-06-10